A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis

NCT02684240 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Nitazoxanide
OTHER: Control

Sponsor

Weill Medical College of Cornell University